Mental Health, Brain Health and Substance Use
Our work involves mental health promotion and the prevention of mental, neurological and substance use disorders. We support the expansion of access to affordable, quality care for everyone who needs it.
Treatment of psychostimulant dependence
2023 updated
Recommendation(s)
Dexamphetamine, methylphenidate and modafinil are not recommended for the treatment of cocaine or stimulant use disorders due to safety concerns.
Strength of recommendation: CONDITIONAL
Certainty of evidence: LOW
[2012]
Recommendation(s)
Dexamphetamine should not be offered for the treatment of stimulant use disorders in non-specialized settings.
Strength of recommendation: STRONG
Quality of evidence: VERY LOW
Evidence Profile
6946 KB